Results 121 to 130 of about 5,177,032 (261)

Outcome of FLAG and FLANG Regimens in the Treatment of Acute Leukemias Patients

open access: yesInternational Journal of Hematology-Oncology and Stem Cell Research, 2012
Introduction: Despite all improvement in the treatment of acute myeloid leukemia (AML) patients, the management in relapsed or refractory disease is still controversial.
Kamran Alimoghaddam   +9 more
doaj  

Extracellular matrix remodeling and immune reprogramming drive residual tumor progression of liver cancer after incomplete microwave ablation

open access: yesMolecular Oncology, EarlyView.
Incomplete microwave ablation (iMWA) of liver cancer triggers a biphasic progression in residual tumors. At Day 3, the microenvironment is characterized by acute inflammatory responses and extracellular matrix (ECM) remodeling. By Day 14, a profound shift occurs toward oncogenic signal transduction and immunosuppression, marked by macrophage ...
Yu Liu   +9 more
wiley   +1 more source

Cell surface CD11c as a neutrophil aging marker molecule

open access: yesFEBS Open Bio, EarlyView.
Cell surface CD11chi neutrophils were more aged and had better phagocytic function than CD11c−/lo neutrophils. Transcriptomic analysis of CD11chi neutrophils and CD11c−/lo neutrophils in pediatric population showed that the most difference was seen in infants.
Sophia Koutsogiannaki   +5 more
wiley   +1 more source

Predicting acute cellular rejection after liver transplantation: form liver function test to immune monitoring [PDF]

open access: yes, 2013
In recent years, the main end point of immunosuppressive therapy after liver transplantation has moved from the prevention of acute cellular rejection (ACR) toward the preservation of long-term graft function and prevention of immunosuppression-related ...
Germani, Giacomo
core  

Blood stem cell collections after mobilization with combination chemotherapy containing ifosfamide followed by G-CSF in multiple myeloma [PDF]

open access: yes, 2003
High-dose chemotherapy with autologous peripheral blood stem cell transplantation is the standard treatment of patients with multiple myeloma today. In this study we used a combination mobilizing chemotherapy containing ifosfamide with G-CSF before stem ...
Werding, N.   +5 more
core   +1 more source

DP099 | BISPECIFIC ANTIBODIES FOLLOWED BY ALLOGENEIC HEMATOPOIETIC STEM CELL TRANSPLANTATION AS RESCUE THERAPY IN REFRACTORY/RELAPSE NON-HODGKIN LYMPHOMA

open access: yesHaematologica
Background: Allogeneic stem cell transplantation (HSCT) emerges as a consolidation option in high-risk lymphoma patients (pts) rescued with bispecific antibodies (BiAb) but data on safety and efficacy are still limited.
G. Facchin   +7 more
doaj  

Understanding and Mitigating the Risk of Accelerated Biological Aging in Survivors of Cancer: A Scoping Review

open access: yesAging and Cancer, EarlyView.
Cancer treatment is associated with measurable acceleration of biological aging across epigenetic, telomere, senescence, and immune biomarkers. However, biomarker validation and interventional strategies remain limited, especially in hematologic malignancies, underscoring the need for standardized multi‐omic aging assessments and adequately powered ...
Moataz Ellithi   +3 more
wiley   +1 more source

Autologous Hematopoietic Stem Cell Transplantation in Acute Lymphoblastic Lymphoma

open access: yesInternational Journal of Hematology-Oncology and Stem Cell Research, 2012
Introduction: Despite high remission rates in acute lymphoblastic leukemia (ALL) patients after induction chemotherapies, post- remission therapies needed to avoiding relapse.
Fatemeh Ghaffari   +10 more
doaj  

Prognostic Value of Neurofilament Light Chain and Glial Fibrillary Acidic Protein in ALD‐Related Myelopathy

open access: yesAnnals of Clinical and Translational Neurology, EarlyView.
ABSTRACT Background X‐linked adrenoleukodystrophy (X‐ALD) is a neurometabolic disorder caused by pathogenic variants in ABCD1, leading to slowly progressive spinal cord disease in nearly all affected men. Sensitive biomarkers to quantify disease severity and predict progression are needed for clinical care and trial design.
Eda G. Kabak   +4 more
wiley   +1 more source

Transplantation of Endothelial Progenitor Cells as Therapeutics for Cardiovascular Diseases [PDF]

open access: yes, 2010
[[abstract]]With better understanding of endothelial progenitor cells (EPCs), many therapeutic approaches to cardiovascular diseases have been developed.
Hung, HS (Hung, Huey-Shan); Shyu, WC (Shyu, Woei-Cherng); Tsai, CH (Tsai, Chang-Hai); Hsu, SH (Hsu, Shan-hui); Lin, SZ (Lin, Shinn-Zong)
core  

Home - About - Disclaimer - Privacy